Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemiaAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Chiara Sartor et al.|Journal of Hematology & Oncology|2018Cited by 56
The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute LeukemiasMaria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Chiara Ronchini et al.|Molecular Cancer Therapeutics|2015Cited by 29
You have accessMine the Stability of the G2/M Checkpoint to Break Down Acute Lymphoblastic Leukemia Defenses Against Antineoplastic DrugsAndrea Ghelli Luserna di Rorà, Yen Timothy, Ilaria Iacobucci et al.|Unknown|2016Cited by 0
Data from The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute LeukemiasMaria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Chiara Ronchini et al.|Unknown|2023Cited by 0
Supplementary Figures S1-S4 from The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute LeukemiasMaria Vittoria Verga Falzacappa, Pier Giuseppe Pelicci, Chiara Ronchini et al.|Unknown|2023Cited by 0